ClinicalTrials.Veeva

Menu

microRNA Expression in Renal Cell Carcinoma

Sun Yat-sen University logo

Sun Yat-sen University

Status

Completed

Conditions

Carcinoma, Renal Cell

Study type

Observational

Funder types

Other

Identifiers

NCT00743054
SYSU-MiRNARCC

Details and patient eligibility

About

In this study, renal cell carcinoma (RCC) related miRNA and the target genes of related miRNA will be examined in order to investigate the role of miRNA in the formation of RCC and look for the biomarker of RCC.

Full description

Due to the lack of specific indicators for the early diagnosis of RCC, the RCC patients often have distant metastasis when diagnosed and their five-year survival rate is much low. Therefore, the biological markers of RCC are needed for early detection, early treatment and improvement of the survival rate of RCC patients.

MiRNA and tumor are closely related. MiRNA can control the important cancer-related genes and participate in the tumor cell proliferation, apoptosis, invasion and angiogenesis.

In this study, RCC related miRNA and the target genes of related miRNA will be examined,and the relationship between RCC related miRNA and the RCC pathological types, TNM (tumor-nodes-metastasis) stages and prognosis will be analyzed. The purpose of this study is to investigate the role of miRNA in the formation of RCC and look for the biomarker of RCC.

Enrollment

50 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with primary renal cell carcinoma.
  • Subjects who agree to participate in the study and sign the informed consent.

Exclusion criteria

  • Patients with secondary renal cell carcinoma.
  • Subjects who refuse to participate in the study and sign the informed consent.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems